China Universal Asset Management Co., Ltd. Biotechnology

China Universal Asset Management Co., Ltd.

$1.05 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
XENE Xenon Pharmaceuticals Inc.	$1.85B	$515,000 0.05% of portfolio	15,353	Q1 2025 Reduced 5.03%
FOLD Amicus Therapeutics, Inc.	$1.75B	$502,000 0.05% of portfolio	61,627	Q1 2025 Reduced 2.73%
VCYT Veracyte, Inc.	$1.94B	$463,000 0.04% of portfolio	15,634	Q1 2025 Reduced 4.86%
ZLAB Zai Lab LTD	$3.04B	$453,000 0.04% of portfolio	12,544	Q1 2025 Added 13.41%
VCEL Vericel Corp	$1.93B	$447,000 0.04% of portfolio	10,023	Q1 2025 Reduced 4.23%
MIRM Mirum Pharmaceuticals, Inc.	$1.62B	$442,000 0.04% of portfolio	9,831	Q1 2025 Reduced 3.42%
IBRX Immunity Bio, Inc.	$1.01B	$440,000 0.04% of portfolio	146,458	Q1 2025 Reduced 0.88%
WVE Wave Life Sciences Ltd.	$526M	$424,000 0.04% of portfolio	52,520	Q1 2025 Reduced 3.22%
RXRX Recursion Pharmaceuticals, Inc.	$736M	$419,000 0.04% of portfolio	79,245	Q1 2025 Reduced 2.1%
EWTX Edgewise Therapeutics, Inc.	$901M	$417,000 0.04% of portfolio	18,993	Q1 2025 Reduced 5.4%
LGND Ligand Pharmaceuticals Inc	$1.72B	$406,000 0.04% of portfolio	3,862	Q1 2025 Reduced 3.62%
DNLI Denali Therapeutics Inc.	$1.77B	$396,000 0.04% of portfolio	29,128	Q1 2025 Reduced 4.55%
TARS Tarsus Pharmaceuticals, Inc.	$1.15B	$395,000 0.04% of portfolio	7,698	Q1 2025 Reduced 5.03%
HRMY Harmony Biosciences Holdings, Inc.	$2B	$381,000 0.04% of portfolio	11,503	Q1 2025 Reduced 4.88%
ARQT Arcutis Biotherapeutics, Inc.	$841M	$372,000 0.04% of portfolio	23,797	Q1 2025 Reduced 4.11%
KYMR Kymera Therapeutics, Inc.	$1.61B	$356,000 0.03% of portfolio	13,027	Q1 2025 Reduced 5.14%
AGIO Agios Pharmaceuticals, Inc.	$1.63B	$336,000 0.03% of portfolio	11,493	Q1 2025 Reduced 4.95%
BEAM Beam Therapeutics Inc.	$1.2B	$332,000 0.03% of portfolio	17,022	Q1 2025 Reduced 4.34%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.63B	$322,000 0.03% of portfolio	25,293	Q1 2025 Reduced 4.14%
JANX Janux Therapeutics, Inc.	$1.05B	$320,000 0.03% of portfolio	11,855	Q1 2025 Added 6.53%
TVTX Travere Therapeutics, Inc.	$1.02B	$318,000 0.03% of portfolio	17,800	Q1 2025 Reduced 2.23%
BCRX Biocryst Pharmaceuticals Inc	$1.97B	$314,000 0.03% of portfolio	41,914	Q1 2025 Reduced 4.57%
VERA Vera Therapeutics, Inc.	$522M	$307,000 0.03% of portfolio	12,787	Q1 2025 Reduced 4.77%
MNKD Mannkind Corp	$1.06B	$306,000 0.03% of portfolio	60,895	Q1 2025 Added 4.14%
IDYA Ideaya Biosciences, Inc.	$905M	$287,000 0.03% of portfolio	17,558	Q1 2025 Reduced 4.2%
CNTA Centessa Pharmaceuticals PLC	$1.21B	$263,000 0.03% of portfolio	18,311	Q1 2025 Reduced 3.16%
DYN Dyne Therapeutics, Inc.	$622M	$237,000 0.02% of portfolio	22,690	Q1 2025 Added 5.17%
IMCR Immunocore Holdings PLC	$1.37B	$235,000 0.02% of portfolio	7,947	Q1 2025 Reduced 5.31%
ARDX Ardelyx, Inc.	$615M	$234,000 0.02% of portfolio	47,810	Q1 2025 Reduced 4.8%
OCUL Ocular Therapeutix, Inc	$565M	$231,000 0.02% of portfolio	31,535	Q1 2025 Reduced 5.4%
INVA Innoviva, Inc.	$1.32B	$227,000 0.02% of portfolio	12,572	Q1 2025 Reduced 5.29%
AUPH Aurinia Pharmaceuticals Inc.	$1.15B	$221,000 0.02% of portfolio	27,548	Q1 2025 Reduced 9.26%
IOVA Iovance Biotherapeutics, Inc.	$281M	$219,000 0.02% of portfolio	65,766	Q1 2025 Added 1.77%
ADPT Adaptive Biotechnologies Corp	$1.28B	$219,000 0.02% of portfolio	29,602	Q1 2025 Reduced 5.4%
ETNB 89bio, Inc.	$427M	$212,000 0.02% of portfolio	29,282	Q1 2025 Added 17.45%
SNDX Syndax Pharmaceuticals Inc	$557M	$210,000 0.02% of portfolio	17,121	Q1 2025 Reduced 5.4%
NVAX Novavax Inc	$577M	$206,000 0.02% of portfolio	32,263	Q1 2025 Reduced 5.01%
GERN Geron Corp	$548M	$203,000 0.02% of portfolio	127,752	Q1 2025 Reduced 0.33%
NRIX Nurix Therapeutics, Inc.	$458M	$180,000 0.02% of portfolio	15,222	Q1 2025 Added 1.34%
VIR Vir Biotechnology, Inc.	$618M	$178,000 0.02% of portfolio	27,509	Q1 2025 Reduced 5.8%
XERS Xeris Biopharma Holdings, Inc.	$659M	$164,000 0.02% of portfolio	29,903	Q1 2025 Reduced 5.4%
DAWN Day One Biopharmaceuticals, Inc.	$461M	$161,000 0.02% of portfolio	20,330	Q1 2025 Reduced 4.92%
REPL Replimune Group, Inc.	$412M	$150,000 0.01% of portfolio	15,448	Q1 2025 Reduced 5.33%
XNCR Xencor Inc	$452M	$150,000 0.01% of portfolio	14,133	Q1 2025 Reduced 4.76%
NTLA Intellia Therapeutics, Inc.	$708M	$147,000 0.01% of portfolio	20,764	Q1 2025 Reduced 3.85%
AVXL Anavex Life Sciences Corp.	$587M	$146,000 0.01% of portfolio	17,062	Q1 2025 Reduced 5.11%
RCKT Rocket Pharmaceuticals, Inc.	$475M	$142,000 0.01% of portfolio	21,388	Q1 2025 Added 10.65%
COGT Cogent Biosciences, Inc.	$324M	$136,000 0.01% of portfolio	22,836	Q1 2025 Reduced 2.5%
ABCL Ab Cellera Biologics Inc.	$565M	$133,000 0.01% of portfolio	59,771	Q1 2025 Reduced 4.56%
PRTA Prothena Corp Public LTD CO	$215M	$133,000 0.01% of portfolio	10,797	Q1 2025 Reduced 5.36%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.